|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.950 CAD | +2.43% |
|
0.00% | -23.38% |
| 06-15 | XORTX Therapeutics Appoints Mika Grasso as Co-CEO; Voluntarily Delisting from the TSX Venture Exchange | MT |
| 06-15 | Xortx Therapeutics Appoints Mika Grasso as Co-CEO; Provides Gout Drug Update | MT |
| Market Cap | 3.63M 2.58M 2.27M 2.11M 1.93M 248M 3.69M 25.02M 9.77M 122M 9.68M 9.47M 422M | P/E 2024 |
-1.02x | P/E 2025 | -1x |
|---|---|---|---|---|---|
| Enterprise Value | 2.8M 1.99M 1.75M 1.63M 1.49M 192M 2.85M 19.32M 7.55M 94.3M 7.48M 7.32M 326M | EV / Sales 2024 |
-
| EV / Sales 2025 | - |
| Free-Float |
91.78% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +2.43% | ||
| Current month | -7.81% | ||
| 1 month | +0.68% | ||
| 3 months | -24.36% | ||
| 6 months | -23.38% | ||
| Current year | -23.38% |
| 1 month | 2.88 |  | 3.2 |
| Current year | 2.42 | | 4.83 |
| 1 year | 2.42 | | 9.85 |
| 3 years | 2.42 | | 49.95 |
| 5 years | 2.42 | | 449.05 |
| 10 years | 2.42 | | 449.05 |
| Manager | Title | Age | Since |
|---|---|---|---|
Mika Grasso
CEO | Chief Executive Officer | 28 | 2026-06-14 |
Allen Davidoff
CEO | Chief Executive Officer | 66 | 2018-01-08 |
Michael Bumby
DFI | Director of Finance/CFO | 62 | 2024-12-18 |
| Director | Title | Age | Since |
|---|---|---|---|
Allen Davidoff
BRD | Director/Board Member | 66 | 2018-01-08 |
| Chairman | 69 | 2022-06-02 | |
Richard Grieve
BRD | Director/Board Member | - | 2026-03-23 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 2/2/26 | Option | Director | 20,000 | 0.2873% | ||
| 2/2/26 | Other | Director | 0 | 0% | ||
| 1/7/26 | Other | Director | 0 | 0% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.43% | 0.00% | -48.25% | -92.87% | 3.62M | |
| -1.92% | +6.03% | +43.68% | +84.56% | 55.92B | |
| +0.93% | +6.97% | +62.83% | +67.97% | 56.67B | |
| -2.97% | -2.35% | -22.03% | -16.54% | 23.28B | |
| -0.46% | -1.29% | +3.28% | +422.58% | 23.28B | |
| -0.36% | +5.73% | +30.99% | -3.58% | 20.54B | |
| -1.34% | +0.51% | +25.02% | -30.27% | 17.78B | |
| -1.44% | +5.67% | +32.54% | +544.11% | 15.9B | |
| -1.30% | -5.02% | +165.62% | +291.37% | 14.64B | |
| -0.50% | -0.98% | +23.62% | +178.38% | 13.99B | |
| Average | -0.69% | -0.01% | +31.73% | +144.57% | 24.2B | |
| Weighted average by Cap. | -0.89% | +1.19% | +41.00% | +135.67% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | - |
| Net income | -3.31M -2.35M -2.07M -1.92M -1.76M -227M -3.36M -22.82M -8.92M -111M -8.83M -8.64M -385M | -2.66M -1.89M -1.66M -1.54M -1.41M -182M -2.7M -18.29M -7.15M -89.3M -7.08M -6.93M -309M |
| Net Debt | -2.43M -1.73M -1.52M -1.41M -1.3M -166M -2.47M -16.77M -6.55M -81.86M -6.49M -6.35M -283M | -827K -587K -516K -480K -440K -56.57M -840K -5.7M -2.23M -27.81M -2.21M -2.16M -96.15M |
Employees
-
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-15 | $0.000000 | -100.00% | 12 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- XRTX Stock
Select your edition
All financial news and data tailored to specific country editions
